Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
The Journal of Investigative Dermatology|May 18, 2007
Langerhans cells and lymph node dendritic cells express the tight junction component claudin-1Simone C Zimmerli, Conrad HauserHuman Immunology|June 3, 2004
Cytomegalovirus (CMV)-specific cellular immune responsesAlexandre Harari, Simone C Zimmerli, Giuseppe PantaleoJournal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
Cutting edge: Lack of evidence for connexin-43 expression in human epidermal Langerhans cellsSimone C Zimmerli, Florence Masson, José Cancela, et al.Experimental Dermatology|December 22, 2007
Human epidermal Langerhans cells express the tight junction protein claudin-1 and are present in human genetic claudin-1 deficiency (NISCH syndrome)Simone C Zimmerli, Katrin Kerl, Smail Hadj-Rabia, et al.Clinical and Translational Allergy|January 22, 2016
Food allergy in mice is modulated through the thymic stromal lymphopoietin pathwayChristophe P Frossard, Simone C Zimmerli, José M Rincon Garriz, et al.Proceedings of the National Academy of Sciences of the United States of America|May 6, 2005
HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cellsSimone C Zimmerli, Alexandre Harari, Cristina Cellerai, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2010
Dibutyl phthalate-induced thymic stromal lymphopoietin is required for Th2 contact hypersensitivity responsesRyan P Larson, Simone C Zimmerli, Michael R Comeau, et al.Microbial Cell Factories|November 8, 2015
Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse modelCamille Aubry, Christophe Michon, Florian Chain, et al.Vaccine|August 17, 2004
Attenuated poxviruses expressing a synthetic HIV protein stimulate HLA-A2-restricted cytotoxic T-cell responsesArnaud Didierlaurent, Juan-Carlos Ramirez, Magdalena Gherardi, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2019
Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease ModelsPhilipp Haselmayer, Montserrat Camps, Lesley Liu-Bujalski, et al.Pageof 2